These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1098179)

  • 21. Bone marrow, blood and assay levels following medication of cats with chloramphenicol ophthalmic ointment.
    Conner GH; Gupta BN
    Vet Med Small Anim Clin; 1973 Aug; 68(8):895-6 passim. PubMed ID: 4490309
    [No Abstract]   [Full Text] [Related]  

  • 22. Assay of antibiotics-streptomycin and chloramphenicol.
    Bose S; Dey GC; Bose BK
    Indian J Physiol Pharmacol; 1966 Oct; 10(4):115-29. PubMed ID: 4965924
    [No Abstract]   [Full Text] [Related]  

  • 23. [Ointments. 8. The effect of the nature of the ointment base and liquid additives on the release of levomycetin from ointments].
    Pertsev IM; Salo DP; Bukhanets' OI; Dmitrievskiĭ DI; Piminov OKh
    Farm Zh; 1974; 0(4):66-72. PubMed ID: 4424800
    [No Abstract]   [Full Text] [Related]  

  • 24. [Investigations on chloramphenicol availability in ophthalmic lamellae].
    Gafitanu E; Zvorişteanu V; Matei I; Braha S; Dorneanu V; Awe B
    Rev Med Chir Soc Med Nat Iasi; 1979; 83(3):519-23. PubMed ID: 16296483
    [No Abstract]   [Full Text] [Related]  

  • 25. [The solubility of drugs in salves and distribution behavior between lipoid and water phases. 2 Distribution between liquid lipids and water].
    Horsch W; Kögel J; Teich C; Wendrich M
    Pharmazie; 1973; 28(11):763-5. PubMed ID: 4791264
    [No Abstract]   [Full Text] [Related]  

  • 26. [Biological availability of ophthalmic drugs. 1. Increasing drug permeability in the cornea].
    Masteiková R; Chalupová Z; Savickiene N
    Ceska Slov Farm; 2004 Mar; 53(2):73-9. PubMed ID: 15095575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioactivity of some chemotherapeutic agents in selected polyethylene glycol ointment bases.
    Farouk A; Béla S; Géza R; Mohamed S; Abdei Hadi I
    Acta Pharm Hung; 1989 Mar; 59(2):87-94. PubMed ID: 2735193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The formulation of eye drops for the Australian and New Zealand Pharmaceutical Formulary.
    LOWE RF
    Trans Ophthalmol Soc Aust; 1954; 14():84-91. PubMed ID: 13256627
    [No Abstract]   [Full Text] [Related]  

  • 29. [Drug liberation from dermatica (author's transl)].
    Smid-Korbar J; Kristl J; Srcic S
    Pharmazie; 1982 May; 37(5):363-6. PubMed ID: 7111363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bioavailability of drugs applied to the eye externally].
    Sieradzki E
    Klin Oczna; 1991 Jan; 93(1):34-6. PubMed ID: 2046287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viscosity of pharmacopeial multimolecular ointment vehicles and pharmaceutical availability of a model therapeutic agent.
    Piechota-Urbańska M; Kołodziejska J; Zgoda MM
    Polim Med; 2007; 37(2):3-19. PubMed ID: 17957945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbiological assay for chloramphenicol residues.
    Singer CJ; Katz SE
    J Assoc Off Anal Chem; 1985; 68(5):1037-41. PubMed ID: 3877048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Eye ointments eubetal and colbiocin in the treatment of chlamydial conjunctivitis].
    Maĭchuk IuF; Vakhova ES
    Vestn Oftalmol; 1998; 114(2):32-4. PubMed ID: 9621818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How to administer eye drops and ointments.
    Shaw M
    Nurs Times; 2014 Oct 1-7; 110(40):16-8. PubMed ID: 26012030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vehicles and excipients in topical ophthalmic therapy].
    ASPERTI G
    Ann Ottalmol Clin Ocul; 1962 Jul; 88():274-8. PubMed ID: 13965269
    [No Abstract]   [Full Text] [Related]  

  • 36. A case of depigmentation following the use of eye drops and steroid ointment.
    Kikuchi I; Horikawa S
    Kumamoto Med J; 1975 Sep; 28(3):145-50. PubMed ID: 1195667
    [No Abstract]   [Full Text] [Related]  

  • 37. [Research on some indigenous hydrogenated fats with a view to using them as a base for ophthalmic ointments].
    Verbuţă A; Bogdan F
    Rev Med Chir Soc Med Nat Iasi; 1978; 82(4):673-6. PubMed ID: 756593
    [No Abstract]   [Full Text] [Related]  

  • 38. TOPICAL SKIN THERAPEUTICS: THE VEHICLE.
    GRAYSON LD
    Skin (Los Angeles); 1963 Oct; 2():319-21. PubMed ID: 14056116
    [No Abstract]   [Full Text] [Related]  

  • 39. Route of absorption of drug and ointment after application to the eye.
    Scruggs J; Wallace T; Hanna C
    Ann Ophthalmol; 1978 Mar; 10(3):267-71. PubMed ID: 655537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. THE VEHICLE AND TOPICAL THERAPY.
    LAZAR P
    Postgrad Med; 1963 Oct; 34():388-91. PubMed ID: 14052420
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.